Bank of America’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bank of America’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-224,236	Closed	-$4.18M	–	8781
2022 Q1	$4.18M	Buy	224,236 +103,178	+85%	+$1.86M	﹤0.01%	3815
2021 Q4	$2.59M	Buy	121,058 +3,634	+3%	+$71.6K	﹤0.01%	4304
2021 Q3	$2.17M	Sell	117,424 -41,009	-26%	-$826K	﹤0.01%	4370
2021 Q2	$3.39M	Sell	158,433 -40,344	-20%	-$820K	﹤0.01%	3872
2021 Q1	$3.83M	Buy	+198,777	New	+$3.5M	﹤0.01%	3670

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's OCDX Position: Q2 2022 in Review

Bank of America sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 224,236 shares — an estimated $4.18M sold.

Bank of America first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $4.18M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Bank of America reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Bank of America sold 224,236 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $4.18M.
Bank of America first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Bank of America's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $4.18M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.